Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RSMDF) Leases (2019 - 2025)

Historic Leases for Resmed (RSMDF) over the last 7 years, with Q4 2025 value amounting to $165.9 million.

  • Resmed's Leases rose 986.94% to $165.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $165.9 million, marking a year-over-year increase of 986.94%. This contributed to the annual value of $167.5 million for FY2025, which is 1083.63% up from last year.
  • Per Resmed's latest filing, its Leases stood at $165.9 million for Q4 2025, which was up 986.94% from $162.0 million recorded in Q3 2025.
  • Resmed's Leases' 5-year high stood at $167.5 million during Q2 2025, with a 5-year trough of $123.4 million in Q3 2023.
  • Over the past 5 years, Resmed's median Leases value was $143.6 million (recorded in 2021), while the average stood at $142.6 million.
  • In the last 5 years, Resmed's Leases tumbled by 1220.38% in 2022 and then surged by 2726.71% in 2024.
  • Resmed's Leases (Quarter) stood at $146.0 million in 2021, then dropped by 12.2% to $128.2 million in 2022, then grew by 19.69% to $153.5 million in 2023, then fell by 1.6% to $151.0 million in 2024, then increased by 9.87% to $165.9 million in 2025.
  • Its Leases was $165.9 million in Q4 2025, compared to $162.0 million in Q3 2025 and $167.5 million in Q2 2025.